Kidney (Neoplasm)

LE WE PMID CA

Kidney (Neoplasm)

1987

Niere (Neubildung)

Adipophilin

Adrenal gland (Neoplasia)

Aquaporin

Bevacizumab ttVEGF

Biomarker (BASKET)

Bladder (Neoplasia)

CD274 PD L1 B7H1

CNS (Neoplasia Neuroblastoma)

Everolimus

Gastrointestinal stromal cell tumor GIST

Gene transfer

Hereditary leiomyomatosis and renal cell carcinoma syndrome

Inflammatory myofibroblastic tumor

Inflammatory pseudotumor

Kidney (Contrast agents induced ARF)

Kidney (CT)

Kidney (Imaging)

Kidney (MRT)

Kidney (Neoplasm)

Kidney (Nephrectomy)

Kidney (Sonography)

Neoplasia (Inherited)

Neoplasia (Radiofrequency ablation)

Neoplasia (Tumor markers)

Neuroendocrine System (Neoplasia Carcinoid)

Pazopanib

Primary pleomorphic undifferentiated sarcoma of the kidney

Primary renal fibrosarcoma

Primary renal mucinous cystadenocarcinoma

Prostate (Neoplasia)

Solitary fibrous tumor of the kidney

Sorafenib

Sunitinib

Temsirolimus

Testis (Neoplasia)

Tuberous sclerosis

Ultrasound (Toxicity and therapeutic use)

Vaccine (Oncology)

VHL

Von Hippel Lindau syndrome

1997 1	Nephron-sparing surgery compared with radical nephrectomy for renal tumors: current indications and results. [9347807] South Med J 90(10): 982-5 (1997)
1991 2	Malignant rhabdoid tumor of the kidney--a case report. [1668958] J Korean Med Sci 6(4): 367-71 (1991)
2009 3	Important aspects of organ-preserving surgery for renal tumors: indications, new standards, and oncological outcomes. [19568369] Dtsch Arztebl Int 106(8): 117-22 (2009)
2008 4	Sunitinib for advanced renal cell cancer. [19707433] Biologics 2(1): 97-105 (2008)
2007 5	Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST). [18360643] Ther Clin Risk Manag 3(2): 341-8 (2007)
2010 6	Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. [20028613] Health Technol Assess 14(2): 1-184, iii-iv (2010)
1992 7	Angiomyolipoma of the kidney: a clinical enigma in diagnosis and management. [1285739] Ann R Coll Surg Engl 74(2): 144-8 (1992)
1974 8	Malignant disease of the kidney. An appraisal of diagnosis and management. [4136033] Ann R Coll Surg Engl 55(1): 21-30 (1974)
1897 9	I. Sarcoma of the Kidney in Children: A Critical Review of the Pathology, Symptomatology, Prognosis, and Operative Treatment as seen in One Hundred and Forty-five Cases. [17860503] Ann Surg 26(5): 529-602 (1897)
2007 10	Understanding the natural biology of kidney cancer: implications for targeted cancer therapy. [17592537] Rev Urol 9(2): 47-56 (2007)
2002 11	Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. [16985675] Rev Urol 4(4): 163-70 (2002)
2010 12	Mixed epithelial and stromal tumor of the kidney or adult mesoblastic nephroma: an update. [20845287] Urol J 7(3): 141-7 (2010)
2010 13	Current management of advanced and metastatic renal cell carcinoma. [20209445] Urol J 7(1): 1-9 (2010)
2009 14	Angiosarcoma of kidney: a case report and review of literature. [19711281] Urol J 6(3): 223-5 (2009)
2008 15	Small renal masses: incidental diagnosis, clinical symptoms, and prognostic factors. [19165347] Adv Urol -(-): 310694 (2008)
2008 16	Genetic counseling in renal masses. [19009041] Adv Urol -(-): 720840 (2008)
2008 17	Open partial nephrectomy in renal cancer: a feasible gold standard technique in all hospitals. [18769498] Adv Urol -(-): 916463 (2008)
2008 18	Familial syndromes coupling with small renal masses. [18695737] Adv Urol -(-): 413505 (2008)
2008 19	Cryoablation for small renal masses. [18645622] Adv Urol -(-): 479495 (2008)
2008 20	Open partial nephrectomy in the management of small renal masses. [18645618] Adv Urol -(-): 309760 (2008)
2008 21	Radiologic evaluation of small renal masses (I): pretreatment management. [19343187] Adv Urol -(-): 415848 (2008)
2008 22	Management of small renal masses. [19343180] Adv Urol -(-): 606401 (2008)
1998 23	Nephron-sparing surgery for renal cell carcinoma. [9772865] Br J Urol 82(3): 321-4 (1998)
1998 24	British urological surgery practice: 2. Renal, bladder and testis cancer. [9598618] Br J Urol 81(4): 513-7 (1998)
1997 25	Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancer. [9240174] Br J Urol 80(1): 18-24 (1997)
2009 26	Metastatic renal cell cancer treatments: an indirect comparison meta-analysis. [19173737] BMC Cancer 9(-): 34 (2009)
2009 27	Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease. [19811659] J Exp Clin Cancer Res 28(-): 134 (2009)
2010 28	Pazopanib for the treatment of patients with advanced renal cell carcinoma. [20981133] Clin Med Insights Oncol 4(-): 95-105 (2010)
2009 29	Review of guidelines on the treatment of metastatic renal cell carcinoma. [19478902] Curr Oncol 16 Suppl 1(-): S67-70 (2009)
2009 30	Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma. [19478895] Curr Oncol 16 Suppl 1(-): S60-6 (2009)
2009 31	Sorafenib in the management of metastatic renal cell carcinoma. [19478894] Curr Oncol 16 Suppl 1(-): S27-32 (2009)
2010 32	New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib. [21049083] Onco Targets Ther 3(-): 147-55 (2010)
2010 33	Renal cell carcinoma: ten years of significant advances. [20703821] Target Oncol 5(2): 73-4 (2010)
2010 34	Perspectives in drug development for metastatic renal cell cancer. [20689997] Target Oncol 5(2): 139-56 (2010)
2010 35	Targeted therapies for non-clear renal cell carcinoma. [20680492] Target Oncol 5(2): 119-29 (2010)
2010 36	Emerging molecular classification in renal cell carcinoma: implications for drug development. [20645016] Target Oncol 5(2): 75-84 (2010)
2010 37	Targeted therapies for renal cell carcinoma: understanding their impact on survival. [20632214] Target Oncol 5(2): 131-8 (2010)
2010 38	Targeted therapy for locally advanced renal cell carcinoma. [20625844] Target Oncol 5(2): 113-8 (2010)
2010 39	Prognostic and predictive biomarkers in renal cell carcinoma. [20582732] Target Oncol 5(2): 85-94 (2010)
2008 40	Temsirolimus in metastatic renal cell carcinoma. [18504249] Ann Oncol 19(8): 1369-70 (2008)
2007 41	Treatment options in renal cell carcinoma: past, present and future. [17761720] Ann Oncol 18 Suppl 10(-): x25-31 (2007)
2007 42	Targeted therapy in metastatic renal cell carcinoma. [17631605] Ann Oncol 18 Suppl 9(-): ix98-102 (2007)
2007 43	Renal cell cancer: is immunotherapy dead? [17631604] Ann Oncol 18 Suppl 9(-): ix94-7 (2007)
2007 44	Temsirolimus in the treatment of advanced renal cell carcinoma. [17631601] Ann Oncol 18 Suppl 9(-): ix87-8 (2007)
2007 45	New challenges in kidney cancer therapy: sunitinib. [17631600] Ann Oncol 18 Suppl 9(-): ix83-6 (2007)
2007 46	Protein kinase inhibitors in the treatment of renal cell carcinoma: sorafenib. [17591826] Ann Oncol 18 Suppl 6(-): vi22-5 (2007)
2007 47	Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet? [17591810] Ann Oncol 18 Suppl 6(-): vi149-52 (2007)
2007 48	Integrated therapy of kidney cancer. [17591809] Ann Oncol 18 Suppl 6(-): vi141-8 (2007)
2007 49	Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma. [17060490] Ann Oncol 18(2): 249-55 (2007)
2006 50	Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review. [16418310] Ann Oncol 17(8): 1185-96 (2006)
2005 51	Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens. [15598929] Ann Oncol 16(1): 7-15 (2005)
2004 52	Current treatment of renal cell carcinoma. [15477330] Ann Oncol 15 Suppl 4(-): iv319-28 (2004)
1996 53	Immunotherapy of metastatic renal cell cancer. [9006738] Ann Oncol 7(9): 887-900 (1996)
2007 54	Recent progress in the management of advanced renal cell carcinoma. [17392388] CA Cancer J Clin 57(2): 112-25 (2007)
1996 55	Current management of renal cell carcinoma. [8806394] CA Cancer J Clin 46(5): 284-302 (1996)
2009 56	Treatment selection for patients with metastatic renal cell carcinoma. [19402069] Cancer 115(10 Suppl): 2327-33 (2009)
2007 57	Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. [17487856] Cancer 109(12): 2439-44 (2007)
2006 58	Treatment outcome for metastatic papillary renal cell carcinoma patients. [17083126] Cancer 107(11): 2617-21 (2006)
2006 59	Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. [16983701] Cancer 107(8): 1793-800 (2006)
2005 60	Targeted agents for the treatment of advanced renal cell carcinoma. [16240452] Cancer 104(11): 2323-33 (2005)
2005 61	Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. [15573369] Cancer 103(1): 68-75 (2005)
2004 62	Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. [15378501] Cancer 101(7): 1545-51 (2004)
1999 63	Fine-needle aspiration biopsy of chromophobe renal cell carcinoma and oncocytoma: comparison of cytomorphologic features. [10385448] Cancer 87(3): 161-7 (1999)
1997 64	Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. [9317170] Cancer 80(7): 1198-220 (1997)
2010 65	Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma. [20861814] Cancer Control 17(4): 269-78 (2010)
2007 66	Laparoscopic management of kidney cancer: updated review. [17615527] Cancer Control 14(3): 218-30 (2007)
2007 67	Cryosurgical ablation of renal cell carcinoma. [17615526] Cancer Control 14(3): 211-7 (2007)
2007 68	Outcomes of radiofrequency ablation for kidney cancer. [17615525] Cancer Control 14(3): 205-10 (2007)
2006 69	Management of locally advanced renal cell carcinoma. [16885916] Cancer Control 13(3): 199-210 (2006)
2007 70	Pseudohypoxic pathways in renal cell carcinoma. [17699843] Clin Cancer Res 13(16): 4667-71 (2007)
2007 71	CCR drug updates: sorafenib and sunitinib in renal cell carcinoma. [17606705] Clin Cancer Res 13(13): 3765-70 (2007)
2007 72	Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. [17332278] Clin Cancer Res 13(5): 1367-73 (2007)
2007 73	Opportunities and obstacles to combination targeted therapy in renal cell cancer. [17255307] Clin Cancer Res 13(2 Pt 2): 764s-769s (2007)
2007 74	The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer. [17255306] Clin Cancer Res 13(2 Pt 2): 758s-763s (2007)
2007 75	Phase 2 studies of sunitinib and AG013736 in patients with cytokine-refractory renal cell carcinoma. [17255305] Clin Cancer Res 13(2 Pt 2): 753s-757s (2007)
2007 76	Sorafenib in renal cell carcinoma. [17255304] Clin Cancer Res 13(2 Pt 2): 747s-752s (2007)
2007 77	Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. [17255303] Clin Cancer Res 13(2 Pt 2): 741s-746s (2007)
2007 78	Update on the application of interleukin-2 in the treatment of renal cell carcinoma. [17255299] Clin Cancer Res 13(2 Pt 2): 716s-720s (2007)
2007 79	Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. [17255296] Clin Cancer Res 13(2 Pt 2): 697s-702s (2007)
2007 80	The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. [17255293] Clin Cancer Res 13(2 Pt 2): 680s-684s (2007)
2006 81	Sorafenib for the treatment of advanced renal cell carcinoma. [17189398] Clin Cancer Res 12(24): 7271-8 (2006)
2006 82	Targeting von Hippel-Lindau pathway in renal cell carcinoma. [17189392] Clin Cancer Res 12(24): 7215-20 (2006)
2004 83	Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma. [15448028] Clin Cancer Res 10(18 Pt 2): 6342S-6S (2004)
2004 84	Debulking nephrectomy in metastatic renal cancer. [15448027] Clin Cancer Res 10(18 Pt 2): 6335S-41S (2004)
2004 85	Review of radiofrequency ablation for renal cell carcinoma. [15448026] Clin Cancer Res 10(18 Pt 2): 6328S-34S (2004)
2004 86	Laparoscopic and partial nephrectomy. [15448025] Clin Cancer Res 10(18 Pt 2): 6322S-7S (2004)
2009 87	Cytoreductive nephrectomy in metastatic clear-cell renal cell carcinoma: perspectives in the tyrosine kinase inhibitor era. [19147692] Oncologist 14(1): 52-9 (2009)
2008 88	Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies. [18838439] Oncologist 13(10): 1084-96 (2008)
2007 89	Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. [18165617] Oncologist 12(12): 1404-15 (2007)
2004 90	An immunophenotypic comparison of metanephric metaplasia of Bowman capsular epithelium with metanephric adenoma, Wilms tumor, and renal development: a case report and review of the literature. [15198357] Am J Clin Pathol 121(6): 850-6 (2004)
2002 91	The time for accurate Fuhrman grading of renal cell carcinomas has arrived. [12472274] Am J Clin Pathol 118(6): 827-9 (2002)
2001 92	Juxtaglomerular cell tumor: a clinicopathologic study of four cases and review of the literature. [11764074] Am J Clin Pathol 116(6): 854-63 (2001)
1996 93	Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites. [8952515] Am J Pathol 149(6): 1791-5 (1996)
1996 94	Comments on different states of secretory autonomy of juxtaglomerular cell tumors of the kidney. [8739773] Intern Med 35(4): 239-40 (1996)
2002 95	Familial adult renal neoplasia. [11826016] J Med Genet 39(1): 1-5 (2002)
2006 96	Prophylaxis strategies for contrast-induced nephropathy. [16788132] JAMA 295(23): 2765-79 (2006)
2009 97	Renal cell carcinoma: biological features and rationale for molecular-targeted therapy. [19398878] Keio J Med 58(1): 1-11 (2009)
2007 98	Medical treatment options in patients with metastatic renal cell carcinoma. [17210591] Nephrol Dial Transplant 22(4): 996-9 (2007)
2008 99	Renal cell carcinoma: diagnosis, staging, and surveillance. [18806169] AJR Am J Roentgenol 191(4): 1220-32 (2008)
2008 100	Benign renal neoplasms in adults: cross-sectional imaging findings. [18094306] AJR Am J Roentgenol 190(1): 158-64 (2008)
2007 101	CT findings after nephron-sparing surgery of renal tumors. [17954623] AJR Am J Roentgenol 189(5): W264-71 (2007)
2007 102	Imaging in metastatic renal cell carcinoma. [17646462] AJR Am J Roentgenol 189(2): 360-70 (2007)
2005 103	Renal medullary carcinoma: CT and MRI features. [15972435] AJR Am J Roentgenol 185(1): 268-72 (2005)
2005 104	Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. [15972401] AJR Am J Roentgenol 185(1): 72-80 (2005)
2005 105	Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. [15972400] AJR Am J Roentgenol 185(1): 64-71 (2005)
2004 106	MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. [14684543] AJR Am J Roentgenol 182(1): 217-25 (2004)
2003 107	Imaging-guided radiofrequency ablation of solid renal tumors. [12760910] AJR Am J Roentgenol 180(6): 1509-13 (2003)
1991 108	Renal oncocytoma. [2028856] AJR Am J Roentgenol 156(6): 1144 (1991)
1988 109	CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. [3044036] AJR Am J Roentgenol 151(3): 497-501 (1988)
2009 110	Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. [19448113] Radiographics 29(3): 741-54; discussion 755-7 (2009)
2008 111	MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. [18635625] Radiographics 28(4): 985-1003 (2008)
2007 112	Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. [17620471] Radiographics 27(4): 1131-43 (2007)
2007 113	Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. [17374857] Radiographics 27(2): 343-55 (2007)
2007 114	CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. [17374856] Radiographics 27(2): 325-39; discussion 339-40 (2007)
2006 115	Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. [17102051] Radiographics 26(6): 1795-806; discussion 1806-10 (2006)
2005 116	Best cases from the AFIP: intrarenal teratoma. [15798064] Radiographics 25(2): 481-5 (2005)
2005 117	Neoplasms of the renal medulla: radiologic-pathologic correlation. [15798056] Radiographics 25(2): 369-80 (2005)
2004 118	Imaging-guided radiofrequency ablation of renal masses. [15486250] Radiographics 24 Suppl 1(-): S59-71 (2004)
2004 119	From the RSNA refresher courses: a practical approach to the cystic renal mass. [15486234] Radiographics 24 Suppl 1(-): S101-15 (2004)
2001 120	Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector ct and three-dimensional CT. [11598260] Radiographics 21 Spec No(-): S237-54 (2001)
2000 121	Pediatric renal masses: Wilms tumor and beyond. [11112813] Radiographics 20(6): 1585-603 (2000)
2000 122	From the archives of the AFIP. Infiltrative renal lesions: radiologic-pathologic correlation. Armed Forces Institute of Pathology. [10682782] Radiographics 20(1): 215-43 (2000)
2000 123	Renal lymphoma: CT patterns with emphasis on helical CT. [10682781] Radiographics 20(1): 197-212 (2000)
1998 124	Nephrogenic rests, nephroblastomatosis, and associated lesions of the kidney. [9672980] Radiographics 18(4): 947-68 (1998)
1991 125	Pediatric case of the day. Congenital mesoblastic nephroma. [1653445] Radiographics 11(4): 719-21 (1991)
2007 126	Renal artery embolisation in the palliative treatment of renal carcinoma. [17495058] Br J Radiol 80(950): 96-102 (2007)
2005 127	How I do it: evaluating renal masses. [16040900] Radiology 236(2): 441-50 (2005)
2003 128	Hereditary renal cancers. [12511666] Radiology 226(1): 33-46 (2003)
2000 129	Case 23: replacement lipomatosis of the kidney. [10831695] Radiology 215(3): 754-6 (2000)
2010 130	Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. [20713607] Radiology 257(1): 135-43 (2010)
1992 131	Imaging of nephroblastomatosis: an overview. [1309213] Radiology 182(1): 1-5 (1992)
1988 132	Nephroblastomatosis: comparison of CT with US and urography. [2827229] Radiology 166(1 Pt 1): 153-6 (1988)
1983 133	Multilocular cystic nephroma: a radiographic-pathologic correlation of 58 patients. [6294736] Radiology 146(2): 309-21 (1983)
2010 134	Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. [20555064] Ann Oncol 21 Suppl 5(-): v137-9 (2010)
2010 135	How to select targeted therapy in renal cell cancer. [20943644] Ann Oncol 21 Suppl 7(-): vii59-62 (2010)
2009 136	Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. [19454473] Ann Oncol 20 Suppl 4(-): 81-2 (2009)
2009 137	Future developments in renal cell carcinoma. [19430003] Ann Oncol 20 Suppl 1(-): i13-17 (2009)
2010 138	Signaling pathways in renal cell carcinoma. [20814228] Cancer Biol Ther 10(7): 658-64 (2010)
2010 139	Percutaneous cryoablation of masses in a solitary kidney. [20489104] AJR Am J Roentgenol 194(6): 1620-5 (2010)
2010 140	How not to miss or mischaracterize a renal cell carcinoma: protocols, pearls, and pitfalls. [20308475] AJR Am J Roentgenol 194(4): W307-15 (2010)
2009 141	Clinical and radiologic features of cystic renal masses. [19380562] AJR Am J Roentgenol 192(5): 1367-72 (2009)
2009 142	Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. [19457819] AJR Am J Roentgenol 192(6): 1558-70 (2009)
2009 143	MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation. [19457820] AJR Am J Roentgenol 192(6): 1571-8 (2009)
2010 144	Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. [21071373] Radiographics 30(6): 1525-40 (2010)
2010 145	Mixed epithelial and stromal tumor of the kidney: radiologic-pathologic correlation. [21071374] Radiographics 30(6): 1541-51 (2010)
2008 146	Pitfalls in renal mass evaluation and how to avoid them. [18794310] Radiographics 28(5): 1325-38 (2008)
2006 147	Molecular pathogenetics of renal cancer. [16733347] Am J Nephrol 26(3): 218-31 (2006)
2004 148	Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. [14654728] Am J Nephrol 24(1): 1-13 (2004)
2010 149	Bevacizumab demonstrates prolonged disease stabilization in patients with heavily pretreated metastatic renal cell carcinoma: a case series and review of the literature. [20721275] Adv Urol -(-): - (2010)
2008 150	New treatments for kidney cancer. [18369205] BMJ 336(7646): 681-2 (2008)
2010 151	Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin? [20435833] Mayo Clin Proc 85(5): 410-2 (2010)
2004 152	The growing family of hereditary renal cell carcinoma. [15507478] Nephrol Dial Transplant 19(12): 2954-8 (2004)
2010 153	Exophytic renal masses: angular interface with renal parenchyma for distinguishing benign from malignant lesions at MR imaging. [20160001] Radiology 255(2): 501-7 (2010)
2007 154	Solid renal cortical tumors: differentiation with CT. [17641370] Radiology 244(2): 494-504 (2007)
2009 155	Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. [19244046] Radiology 250(3): 793-802 (2009)
2008 156	Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience. [18430878] Radiology 247(2): 458-64 (2008)
2010 157	Tubulocystic carcinoma of the kidney: a case report of natural history and long-term follow-up. [20364244] ScientificWorldJournal 10(-): 586-9 (2010)
2007 158	Radiofrequency ablation of renal tumors. [18070691] Tech Vasc Interv Radiol 10(2): 132-9 (2007)
2010 159	Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. [20875347] Discov Med 10(52): 255-62 (2010)
2010 160	Targeted therapy for renal cell cancer: current perspectives. [21122471] Discov Med 10(54): 394-405 (2010)
2009 161	VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. [18950731] Int J Biochem Cell Biol 41(4): 753-6 (2009)
2010 162	New strategies in kidney cancer: therapeutic advances through understanding the molecular basis of response and resistance. [20179240] Clin Cancer Res 16(5): 1348-54 (2010)
2010 163	Everolimus. [20179227] Clin Cancer Res 16(5): 1368-72 (2010)
2010 164	Advances in the genetics of familial renal cancer. [20484339] Oncologist 15(6): 532-8 (2010)
2010 165	Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: a review. [20215359] Oncologist 15(3): 236-45 (2010)
2010 166	FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma. [20332142] Oncologist 15(4): 428-35 (2010)
2010 167	FDA drug approval summary: bevacizumab plus interferon for advanced renal cell carcinoma. [20061402] Oncologist 15(1): 104-11 (2010)
2009 168	Combination systemic therapy for advanced renal cell carcinoma. [19939892] Oncologist 14(12): 1218-24 (2009)
2002 169	Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature. [11815966] Cancer 94(1): 111-6 (2002)
2010 170	Sunitinib rechallenge in metastatic renal cell carcinoma patients. [21105118] Cancer 116(23): 5400-6 (2010)
2009 171	Sequential therapy in renal cell carcinoma. [19402067] Cancer 115(10 Suppl): 2321-6 (2009)
2009 172	Magnetic resonance imaging as a biomarker in renal cell carcinoma. [19402070] Cancer 115(10 Suppl): 2334-45 (2009)
2009 173	Complexity of tumor vasculature in clear cell renal cell carcinoma. [19402071] Cancer 115(10 Suppl): 2282-9 (2009)
2009 174	Targeting mTOR in renal cell carcinoma. [19402072] Cancer 115(10 Suppl): 2313-20 (2009)
2009 175	Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma. [19402073] Cancer 115(10 Suppl): 2306-12 (2009)
2009 176	Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma. [19402074] Cancer 115(10 Suppl): 2346-54 (2009)
2009 177	Hereditary kidney cancer: unique opportunity for disease-based therapy. [19402075] Cancer 115(10 Suppl): 2252-61 (2009)
2009 178	Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein. [19402056] Cancer 115(10 Suppl): 2262-72 (2009)
2009 179	Tissue biomarkers in renal cell carcinoma: issues and solutions. [19402057] Cancer 115(10 Suppl): 2290-7 (2009)
2009 180	Combination targeted therapy in advanced renal cell carcinoma. [19402058] Cancer 115(10 Suppl): 2368-75 (2009)
2009 181	Novel therapeutics for metastatic renal cell carcinoma. [19402059] Cancer 115(10 Suppl): 2361-7 (2009)
2009 182	Immunotherapy of metastatic renal cell carcinoma. [19402060] Cancer 115(10 Suppl): 2298-305 (2009)
2009 183	Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. [19402064] Cancer 115(10 Suppl): 2247-51 (2009)
2009 184	Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. [19402065] Cancer 115(10 Suppl): 2273-81 (2009)
2006 185	Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. [16585157] Cancer Res 66(7): 3381-5 (2006)
2010 186	Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. [21047490] Health Technol Assess 14(Suppl. 2): 41-6 (2010)
2004 187	Caval involvement of renal cell carcinoma. [15285567] Scand J Surg 93(2): 145-9 (2004)
2004 188	Surgery for metastases of renal cell carcinoma. [15285568] Scand J Surg 93(2): 150-5 (2004)
2004 189	Inherited forms of renal cell carcinoma. [15285561] Scand J Surg 93(2): 103-11 (2004)
2004 190	Minimally invasive treatments in renal cell carcinoma. [15285566] Scand J Surg 93(2): 137-44 (2004)
2007 191	Renal and adrenal tumours in children. [17339140] Cancer Imaging 7(-): 41-51 (2007)
2005 192	Best Practice No 180. Nephrectomy for renal tumour; dissection guide and dataset. [15623474] J Clin Pathol 58(1): 7-14 (2005)
2007 193	Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm? [17557864] J Clin Pathol 60(6): 585-6 (2007)
2007 194	Renal veins and venous extension in clear cell renal cell carcinoma. [17170742] Mod Pathol 20(1): 44-53 (2007)
2009 195	Uncommon and recently described renal carcinomas. [19494850] Mod Pathol 22 Suppl 2(-): S2-S23 (2009)
2009 196	Advances and controversies in grading and staging of renal cell carcinoma. [19494851] Mod Pathol 22 Suppl 2(-): S24-36 (2009)
2002 197	Understanding familial and non-familial renal cell cancer. [12351585] Hum Mol Genet 11(20): 2489-98 (2002)
2009 198	Renal cystic diseases and renal neoplasms: a mini-review. [19875768] Clin J Am Soc Nephrol 4(12): 1998-2007 (2009)
2010 199	High intensity focused ultrasound treatment of small renal masses: Clinical effectiveness and technological advances. [21116349] Indian J Urol 26(3): 331-7 (2010)
2008 200	Prognostic biomarkers of renal cell carcinoma: Recent advances. [19468351] Indian J Urol 24(1): 10-5 (2008)
2009 201	Staging of renal cell carcinoma: Current concepts. [19955666] Indian J Urol 25(4): 446-54 (2009)
2009 202	Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future. [19955664] Indian J Urol 25(4): 427-36 (2009)
2011 203	Management of the small renal mass: what is the most reasonable option? [21806319] Expert Rev Anticancer Ther 11(7): 977-80 (2011)
2011 204	Nephron-sparing surgery versus radical nephrectomy for kidney tumors: benefits and limitations. [21707272] Expert Rev Anticancer Ther 11(6): 805-8 (2011)
2011 205	The potential of virus-based gene therapies for treatment of metastatic kidney cancer. [21707273] Expert Rev Anticancer Ther 11(6): 809-11 (2011)
2010 206	Patient-based strategy for systemic treatment of metastatic renal cell carcinoma. [20397923] Expert Rev Anticancer Ther 10(4): 585-96 (2010)
2008 207	VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment. [18095884] Expert Rev Anticancer Ther 8(1): 63-73 (2008)
2010 208	MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. [20964839] BMC Med 8(-): 65 (2010)
2009 209	Laparoscopic partial nephrectomy: the University of Saskatchewan (Regina division) experience. [19424463] Can Urol Assoc J 3(2): 111-8 (2009)
2009 210	Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. [19424470] Can Urol Assoc J 3(2): 143-9 (2009)
2010 211	Malignant tumours of the kidney: imaging strategy. [20432020] Pediatr Radiol 40(6): 1010-8 (2010)
2010 212	Contrast enhanced ultrasound of renal masses. [21160736] World J Radiol 2(1): 15-31 (2010)
2008 213	Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report. [18319033] Dermatol Online J 14(1): 16 (2008)
2011 214	Inflammatory pseudotumor of the kidney: a case report. [21864369] J Med Case Reports 5(1): 411 (2011)
2008 215	Cystic nephroma: a case report and review of the literature. [18947428] Cases J 1(1): 267 (2008)
2005 216	Carcinoid tumor of the kidney: case report and review of the literature. [16985835] Rev Urol 7(4): 229-33 (2005)
2009 217	The evolving management of small renal masses. [19336013] Curr Oncol Rep 11(3): 211-7 (2009)
2010 218	Molecular diagnosis and therapy of kidney cancer. [20059341] Annu Rev Med 61(-): 329-43 (2010)
2011 219	Imaging of renal cell carcinoma: state of the art and recent advances. [21150177] Urol Int 86(2): 125-39 (2011)
2009 220	Focal therapy for kidney cancer: a systematic review. [19188769] Curr Opin Urol 19(2): 148-53 (2009)
2010 221	Epidemiology and risk factors for kidney cancer. [20448658] Nat Rev Urol 7(5): 245-57 (2010)
2010 222	Long-term management of bilateral, multifocal, recurrent renal carcinoma. [20448660] Nat Rev Urol 7(5): 267-75 (2010)
2010 223	The genetic basis of kidney cancer: a metabolic disease. [20448661] Nat Rev Urol 7(5): 277-85 (2010)
2008 224	Renal masses--to treat or not to treat? If that is the question are contemporary biomarkers the answer? [18550098] J Urol 180(2): 433-4 (2008)
2011 225	A rare renal epithelial tumor: mucinous cystadenocarcinoma case report and review of the literature. [22110514] Case Report Med 2011(-): 686283 (2011)
2009 226	Solitary fibrous tumor of the kidney: a case report. [19796466] Can J Urol 16(5): 4854-6 (2009)
2008 227	Primary renal fibrosarcoma: a rare case report and review of literature. [18723974] Indian J Pathol Microbiol 51(3): 409-10 (2008)
2008 228	Primary pleomorphic undifferentiated sarcoma of the kidney: a rare renal tumor. [19008608] Indian J Pathol Microbiol 51(4): 573-6 (2008)
2011 229	Management of small renal masses--update 2011. [21776295] J Med Life 4(2): 139-47 (2011)
2010 230	Small Incidental Renal Masses in Adults: Review of the literature. [21509229] Sultan Qaboos Univ Med J 10(2): 196-202 (2010)
2010 231	Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety. [21098204] AJR Am J Roentgenol 195(6): 1418-22 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Neoplasm).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Neoplasm).php on line 92